Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Chronic inflammation contributes to multiple diseases including cardiovascular diseases, autoimmune disorders, metabolic disorders, and psychiatric conditions. Melatonin, a hormone responsible for circadian rhythm, plays a complex role within the immune system, including having an anti-inflammatory effect. While there are numerous animal studies demonstrating this effect, few human clinical trials have been conducted. This systematic review of clinical trials examined whether exogenous melatonin reduces levels of inflammatory markers in humans. We searched PubMed, Embase, Cochrane Library, Scopus, and PsycINFO, and the references of the identified articles for randomized and non-randomized placebo-controlled trials. Data were extracted from the articles and meta-analyses were conducted using a random effects model to calculate standardized mean differences (SMDs, i.e., Cohen’s d). From an initial search result of 4548 references, 31 studies met the inclusion criteria and were included involving 1517 participants. Melatonin had significant anti-inflammatory effects on interleukin (IL)-1 (SMD −1.64; 95% confidence interval [CI] −2.86, −0.43; p=0.008), IL-6 (−3.84; −5.23, −2.46; p<0.001), IL-8 (−21.06; −27.27, −14.85; p<0.001), and tumor necrosis factor (TNF) (−1.54; −2.49, −0. 58; p=0.002), but not on C-reactive protein (CRP) (−0.18; −0.91, 0.55; p=0.62). Trimming outlier studies with large effect sizes eliminated publication bias, and summary effect sizes were significant for IL-1 (SMD −1.11; 95% CI −1.90, −0.32; p=0.006), IL-6 (−1.91; −2.98, −0.83; p=0.001), and IL-8 (−13.46; −18.88, −8.04; p<0.001), but not for TNF (−0.45; −1.13, 0.23; p=0.19). Exogenous melatonin reduced levels of inflammatory markers and may be useful for prevention and adjuvant treatment of inflammatory disorders. Melatonin is safe with few side effects, which makes it an excellent agent for prevention of inflammatory disorders. Because chronic inflammation increases with aging and inflammation plays a role in the etiology of numerous diseases that affect older populations, melatonin has the potential to be widely used particularly in older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Raygan, F., Ostadmohammadi, V., Bahmani, F., Reiter, R. J., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.12.004 · Cited by 147
RetractedCochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“Introduction Chronic inflammation plays a key role in the pathophysiology of numerous common diseases including cardiovascular diseases, autoimmune disorders, metabolic disorders, and psychiatric conditions (Furman et al., 2019).”
BackgroundIrwin, M. R., Olmstead, R., & Carroll, J. E. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.014 · Cited by 2,085 · cited 1×
“Also, sleep disturbance itself increases systemic inflammation (Irwin et al., 2016).”
BackgroundSelf-citationEffects of exogenous melatonin on sleep: a meta-analysis
Brzezinski, A., Vangel, M. G., Wurtman, R. J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.06.004 · Cited by 541 · cited 1×
“Additionally, there is meta-analytic evidence on the small but significant effect of melatonin in improving primary sleep disorders (Auld et al., 2017; Brzezinski et al., 2005; Buscemi et al., 2005; Ferracioli-Oda et al., 2013).”
BackgroundThe efficacy and safety of exogenous melatonin for primary sleep disorders a meta-analysis
Buscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., Baker, G., Klassen, T. P., & Vohra, S. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0243.x · Cited by 399 · cited 1×
“Additionally, there is meta-analytic evidence on the small but significant effect of melatonin in improving primary sleep disorders (Auld et al., 2017; Brzezinski et al., 2005; Buscemi et al., 2005; Ferracioli-Oda et al., 2013).”
BackgroundMelatonin: A Pleiotropic Molecule Regulating Inflammation
Radogna, F., Diederich, M., & Ghibelli, L. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.041 · Cited by 342 · cited 4×
“In the late inflammation phase, which refers to chronic inflammation responsible for many disease processes, melatonin exerts anti-inflammatory effects by downregulating the aforementioned inflammatory mediators and pro-inflammatory cytokines and also by reducing oxidative stress (Radogna et al., 2010).”
BackgroundInfluentialThe effect of probiotics on inflammatory biomarkers: A meta-analysis of randomized clinical trials
Milajerdi, A., Mousavi, S. M., Sadeghi, A., Salari-Moghaddam, A., Parohan, M., Larijani, B., & Esmaillzadeh, A. (2020) · European Journal of Nutrition · doi:10.1007/s00394-019-01931-8 · Cited by 123 · cited 1×
“5 for various inflammatory markers) (Li et al., 2018; Lv et al., 2015; Milajerdi et al., 2020; Mousa et al., 2018; Tabrizi et al., 2019; Xin et al., 2012).”
Mesri Alamdari, N., Mahdavi, R., Roshanravan, N., Lotfi Yaghin, N., Ostadrahimi, A., & Faramarzi, E. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1384587 · Cited by 93
Cited by
Skin Pigmentation Types, Causes and Treatment—A Review
Thawabteh, A. M., Jibreen, A., Karaman, D., Thawabteh, A., & Karaman, R. (2023) · Molecules · doi:10.3390/molecules28124839 · Cited by 233
Metadata
- Authors
- Cho, J. H., Bhutani, S., Kim, C. H., & Irwin, M. R.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 93
- Pages
- 245-253
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W3128092763
- Cited by
- 168
- References
- 9
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.